Korea BNC Rises 6.28% Amid Uptrend in COVID-19 (Treatment/Vaccine Development) Theme

On the 18th, the COVID-19 (treatment/vaccine development, etc.) theme rose by 3.03% compared to the previous day, showing strength, while Korea BNC, which is attracting attention as a related stock, surged by 6.28% compared to the previous day.

[Graph] Major stock price changes in the COVID-19 (treatment/vaccine development, etc.) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Korea BNC's quant financial score is 28.48 points, which is higher in growth and profitability scores than the average of other stocks related to the COVID-19 (treatment/vaccine development, etc.) theme, ranking 8th within the theme. This indicates that compared to other stocks in the theme, Korea BNC's sales and net income growth rates are relatively fast, and its efficient profit-generating ability is also good.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.